Reta staat voor Retatrutide, een nieuw afslankmiddel van de Amerikaanse farmaceut Eli Lilly
Not through a crash diet or excessive exercise, but with the help of a weekly injection thats fundamentally changed how their body processes food
For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
If both pivotal trials deliver results as strong as or stronger than TRIUMPH-4, Lilly could submit the NDA as early as Q3 2026 rather than Q4, shaving 1 to 3 months off the timeline
A Whole-Pathway Approach
Tirzepatide is a one-of-a-kind drug only meant for individuals who are overweight or obese, i.e., those with a BMI of 27 or more and have a weight-related condition, such as diabetes, or those with a BMI of 30 or more